decentralized clinical trials

Able Biolabs provides preclinical and clinical R&D services for clients in the biotech and consumer goods industries. Led by PhD and MD-level scientists, it operates non-GLP facilities and partners with organizations such as SRI and the University of Alabama at Birmingham for specialized analyses, GLP work, and advisory support. The company conducts decentralized randomized controlled clinical trials and consumer studies for CPG brands.

Read more

air-liquid interfacecell-based modelsconsumer studiesex vivo approachesorganoidsprotocol development and validationsmall animal studies